Gene · 29968
Papers1,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity. | Front Immunol | 2023 | 37675104 | PubTator, text mining | PubMed |
| Stromal cells in the tumor microenvironment: accomplices of tumor progression? | Cell Death Dis | 2023 | 37666813 | PubTator, text mining | PubMed |
| The Commit to Be Fit framework: a community case study of a multi-level, holistic school-based wellness initiative in rural Virginia. | Front Public Health | 2023 | 37663842 | PubTator, text mining | PubMed |
| MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells. | Endocr Relat Cancer | 2023 | 37650685 | PubTator, text mining | PubMed |
| Aminooxy acetic acid suppresses Th17-mediated psoriasis-like skin inflammation by inhibiting serine metabolism. | Front Pharmacol | 2023 | 37649889 | PubTator, text mining | PubMed |
| Contribution of the Nuclear Localization Sequences of Influenza A Nucleoprotein to the Nuclear Import of the Influenza Genome in Infected Cells. | Viruses | 2023 | 37631984 | PubTator, text mining | PubMed |
| Phosphoserine Aminotransferase Pathogenetic Variants in Serine Deficiency Disorders: A Functional Characterization. | Biomolecules | 2023 | 37627284 | Swiss-Prot, curated | PubMed |
| Metabolic Heterogeneity, Plasticity, and Adaptation to "Glutamine Addiction" in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase-ω-Amidase (Glutaminase II)] Pathway. | Biology (Basel) | 2023 | 37627015 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| Influence of diatomite and its base modifications on the self-adhesive properties of silicone pressure-sensitive adhesives. | Sci Rep | 2023 | 37608088 | PubTator, text mining | PubMed |
| Mitochondrial heterogeneity in diseases. | Signal Transduct Target Ther | 2023 | 37607925 | PubTator, text mining | PubMed |
| Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α. | Mol Oncol | 2023 | 37584455 | PubTator, text mining | PubMed |
| YAP/TAZ: Molecular pathway and disease therapy. | MedComm (2020) | 2023 | 37576865 | PubTator, text mining | PubMed |
| Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer. | Cell Death Dis | 2023 | 37573361 | PubTator, text mining | PubMed |
| Molecular mechanisms of multi-omic regulation in breast cancer. | Front Oncol | 2023 | 37564937 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| eIF3f Mediates SGOC Pathway Reprogramming by Enhancing Deubiquitinating Activity in Colorectal Cancer. | Adv Sci (Weinh) | 2023 | 37544925 | PubTator, text mining | PubMed |
| A novel machine learning-based programmed cell death-related clinical diagnostic and prognostic model associated with immune infiltration in endometrial cancer. | Front Oncol | 2023 | 37534256 | PubTator, text mining | PubMed |
| Increased serine synthesis in cumulus cells of young infertile women with diminished ovarian reserve. | Hum Reprod | 2023 | 37533289 | PubTator, text mining | PubMed |
| ZEB1 Fuels Serine Metabolism to Promote HCC Metastasis. | Cell Mol Gastroenterol Hepatol | 2023 | 37517803 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29968/papers?page=12